doi: 10.1111/dom.13024
However, it is important to remember that individual results will vary, with some people losing less weight and others losing more
The American Diabetes Association and a group of obesity expert orgs have released statements advising patients against using them due to the potential for content and quality issues
Clinical trials show tirzepatide produces greater average weight loss than semaglutide monotherapyapproximately 2022% body weight reduction compared to 1518% with semaglutide alone
Vanella A, Russo A, Acquaviva R, Campisi A, Di Giacomo C, Sorrenti V, Barcellona ML: L -propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector
Its important to note that coverage for weight loss medications can vary based on specific plans and state regulations